In addition, STING activation also enhanced the expression of PD-L1 and CCR2 in multiple mouse tumors, including colon cancer, tongue squamous carcinoma, and head and neck squamous cell carcinoma [111, 167]. The gene discussed is STING1; the disease is colonic neoplasm.